[ET Net News Agency, 27 October 2021] Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
(02196) said for the three months ended 30 September 2021, net profit attributable to
shareholders of the listed company was RMB1.08 billion, a year-on-year increase of 41.62%.
Basic earnings per share were RMB0.42.
Operating revenue was RMB10.10 billion, a year-on-year increase of 25.03%. (RC)